Understanding the APOE4 Gene's Role in Alzheimer's Disease

Recent research has highlighted the significant impact of the APOE4 gene variant on brain activity, particularly in relation to Alzheimer's disease. Carrying one or two copies of the APOE4 gene markedly increases the risk of developing Alzheimer's. A study conducted on young mice genetically modified to possess the APOE4 variant revealed that specific neurons in the hippocampus, a critical area for memory, were smaller and exhibited hyperactivity. This hyperactivity was observed long before any cognitive symptoms, such as memory loss, became apparent. The study's senior author, Misha Zilberter, noted that these fundamental changes in brain circuits could predict cognitive deficits in older ages.

ScienceAlert

The research identified a protein called Nell2 as a contributing factor to the neuronal disruptions associated with the APOE4 variant. In the study, the neurons of APOE4 mice were found to be more excitable and easier to stimulate compared to those of mice with the APOE3 variant, which is linked to a lower risk of Alzheimer's. Notably, the neurons in APOE3 mice only became more active in old age and did not develop cognitive problems like their APOE4 counterparts. When researchers intervened to block the production of Nell2 in the APOE4 mice, the neurons reverted to normal size and firing patterns, suggesting a potential pathway for reversing damage in advanced cases.

ScienceAlert

The findings from this study indicate that the damage caused by the APOE4 gene may not be irreversible. Yadong Huang, another neuroscientist involved in the research, emphasized the potential for intervention even after the onset of disease processes. This research aligns with previous studies that have linked high levels of Nell2 to Alzheimer's patients, marking a significant step in understanding the genetic factors influencing the disease. The study opens avenues for developing therapies aimed at blocking the detrimental effects of APOE4 early in life, potentially mitigating the risk of cognitive decline.

ScienceAlert

While the study presents promising insights, Alzheimer's disease remains a complex condition influenced by multiple risk factors. Critics may argue that focusing solely on genetic factors like APOE4 could overshadow other critical elements contributing to the disease's progression. The challenge lies in comprehensively understanding how these various risk factors interact and influence one another.

ScienceAlert

• “To the best of our knowledge, this is the first study that has directly examined what APOE4 does to the function of neurons at different ages,” — Misha Zilberter, Neuroscientist, Gladstone Institute of Neurological Disease

ScienceAlert

• “What's exciting about Nell2 is that we were able to reverse the disease manifestations in adult mice by lowering its level,” — Yadong Huang, Neuroscientist, Gladstone Institute of Neurological Disease

ScienceAlert

• “[This study] opens the door to a better understanding of how APOE4 alters the function of neurons at a young age to increase risk of cognitive decline, and to the development of therapies that could block the detrimental effects of APOE4 early on,” — Yadong Huang, Neuroscientist, Gladstone Institute of Neurological Disease

ScienceAlert

This research, published in *Nature Aging*, underscores the importance of understanding the genetic underpinnings of Alzheimer's disease and the potential for developing targeted interventions.

ScienceAlert